IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 23 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,000 | -72.2% | 276,530 | +219.6% | 0.00% | -50.0% |
| Q3 2018 | $18,000 | -18.2% | 86,530 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $22,000 | 0.0% | 86,530 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $22,000 | -18.5% | 86,530 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $27,000 | +17.4% | 86,530 | +40.6% | 0.00% | 0.0% |
| Q3 2017 | $23,000 | -28.1% | 61,530 | +64.1% | 0.00% | -25.0% |
| Q2 2017 | $32,000 | – | 37,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 231,736 | $58,000 | 0.00% |
| WEDBUSH SECURITIES INC | 86,530 | $22,000 | 0.00% |
| BARCLAYS PLC | 50 | $0 | 0.00% |
| Avantax Planning Partners, Inc. | 74 | $0 | 0.00% |
| VANGUARD GROUP INC | 79,566 | $20,000 | 0.00% |
| UBS Group AG | 33,627 | $8,000 | 0.00% |
| Tradewinds Capital Management, LLC | 200 | $0 | 0.00% |
| IFP Advisors, Inc | 95 | $0 | 0.00% |
| Jacobi Capital Management LLC | 125 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 250 | $0 | 0.00% |